22.49BMarket Cap-10.69P/E (TTM)
21.250High20.050Low2.29MVolume20.050Open20.000Pre Close47.68MTurnover0.21%Turnover RatioLossP/E (Static)1.09BShares25.80052wk High4.33P/B22.49BFloat Cap10.56052wk Low--Dividend TTM1.09BShs Float151.200Historical High--Dividend LFY6.00%Amplitude10.560Historical Low20.827Avg Price100Lot Size--Div YieldTTM--Div Yield LFY
ZAI LAB Stock Forum
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has received Orphan Drug Designation (ODD) from the U.S. FDA for ZL-1310, their first-in-class DLL3 antibody-drug conjugate (ADC) designed to treat small cell lung cancer (SCLC). The designation comes after promising results from an ongoing Phase 1a/1b study in patients with previously treated extensive-stage SCL...
No comment yet